Search for Clinical Trial Results

Sponsored By

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - 25 Studies Found

Status Study
Completed Study Name: Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Date: 2009-11-06
Interventions: Drug: Subcutaneous immunoglobulin The subcutaneous immunoglobulin is infused in the subcutaneous tissue
Completed Study Name: Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Date: 2005-09-13
Interventions:
  • Drug: Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified

Completed Study Name: Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.
Condition: Chronic Inflammatory Demyelinating Polyneuropathy
Date: 2013-04-01
Interventions: Drug: NPB-01 Other Name: Intravenous immunoglobulin
Completed Study Name: Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.
Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Date: 2012-06-19
Interventions:
  • Drug: Fingolimod
  • Drug: Placebo Comparator
Completed Study Name: Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Condition: Chronic Inflammatory Demyelinating Polyneuropathy
Date: 2011-06-16
Completed Study Name: Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy
Condition: Chronic Inflammatory Demyelinating Polyneuropathy
Date: 2010-08-18
Interventions: Biological: 10% liquid formulation of human immunoglobulin Other Name: IgPro10; Privigen
Completed Study Name: Study of CIDP Patients During IVIG Treatment
Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Date: 2006-03-20
Interventions: Drug: intravenous gammaglobulin individual dose
Withdrawn Study Name: High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy
Condition: Chronic Inflammatory Demyelinating Polyneuropathy
Date: 2010-11-05
Interventions: Drug: Cyclophosphamide
Active, not recruiting Study Name: Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Condition:
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Date: 2014-01-03
    Interventions: Biological: IgPro20
Completed Study Name: Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Date: 2004-12-15
Interventions: Drug: Interferon Beta-1a
Next >>>